Alunbrig
Payments companies reported to CMS as associated with Alunbrig. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alunbrig, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alunbrig
These are the largest totals companies reported as associated with Alunbrig. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mohammad Jahanzeb | Boca Raton, FL | Medical Oncology | $191,886.21 |
| Martin Dietrich | Rockledge, FL | Hematology & Oncology | $134,303.29 |
| Edgardo Santos | Fort Lauderdale, FL | Hematology & Oncology | $66,004.16 |
| Edmund Tai | Mountain View, CA | Anatomic Pathology & Clinical Pathology | $60,306.91 |
| Mahdi Taha | Boca Raton, FL | Medical Oncology | $36,563.96 |
| Abhirami Vivekanandarajah | Staten Island, NY | Hematology & Oncology | $31,751.76 |
| Jessica Lin | Boston, MA | Medical Oncology | $27,959.82 |
| Miguel Albino | Austin, TX | Medical Oncology | $25,707.62 |
| Sujith Kalmadi | Chandler, AZ | Hematology & Oncology | $22,962.96 |
| Yuanbin Chen | Orlando, FL | Medical Oncology | $22,282.40 |
Prescribed Alunbrig?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.